Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Plight of the Retail Pharmacist

Philip Seo, MD, MHS  |  Issue: March 2020  |  March 12, 2020

In 2000, the Doctor of Pharmacy degree became the entry-level pharmacy degree. This clinical degree gives pharmacists education & patient experience they would be eager to put to work—if only they had enough time to do so.

To Err Is EMR

Traditionally, prescribing errors are the fault of the prescribing physician. A multi­disciplinary panel of physicians, surgeons, pharmacists, nurses and risk managers, defined a prescribing error as “when, as a result of a prescribing decision or prescription writing process, there is an unintentional, significant 1) reduction in the probability of treatment being timely and effective or 2) increase in the risk of harm when compared with generally accepted practice.”1

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The increasing use of electronic medical records (EMRs) and electronic prescribing has removed a major source of prescribing errors—physician handwriting. I remember as a senior resident doing handwriting consults for interns, helping them interpret the instructions the attending physicians scribbled in the paper chart. I am certain most pharmacists have the same experience. Electronic prescribing has removed the uncertainty that used to come from trying to distinguish the abbreviations for magnesium sulfate and morphine sulfate.

This was no mean feat. On Dec. 1, 1999, the Institute of Medicine released a report on medical errors. The report estimated that 1.5 million adverse events and 7,000 deaths occurred in the U.S. each year as the result of prescribing errors, many of which could be traced back to poor handwriting.2 This report, titled To Err Is Human: Building a Safer Health System, was designed to increase awareness of medical errors and was largely responsible for the push to transition to electronic prescribing.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

For the most part, this transition accomplished what it was supposed to. One study demonstrated a 70% reduction in errors following a transition to electronic prescribing, largely attributed to elimination of errors due to illegibility, inappropriate abbreviations, and incomplete prescriptions.3 And were it not for the law of unintended consequences, the transition to electronic prescribing might have been an unequivocal victory. Unfortunately, EMRs, perhaps predictably, gave rise to a new generation of prescribing errors, which include the following:4

  • Autopopulation: Most EMRs automatically suggest a list of potential matches as soon as you start to type the first few letters of the drug name. Only a few millimeters of space may separate penicillin from penicillamine, or azithromycin from azathioprine;
  • Alert fatigue: Clinicians face a high burden of automatically generated alerts. Some of these are valuable, but are buried under a deluge of nonsensical or repetitive warnings, which dilute the potential of this feature; and
  • Default values: EMRs may default to specific quantities or doses, which may be incorrect.

An illegible prescription, while annoying, was easy enough to flag. Who is responsible for catching this new generation of subtle prescribing errors? The pharmacist.

Page: 1 2 3 4 5 | Single Page
Share: 

Filed under:EMRsLegislation & AdvocacyOpinionRheuminationsSpeak Out Rheum Tagged with:pharmacy benefit managers (PBMs)Prescription drugs

Related Articles

    Advantages of Embedding a Specialty Pharmacist in a Rheumatology Clinic

    November 12, 2020

    The number of medications with rheumatologic indications has increased in parallel with expanding complexities of medication approval and delivery. Simply starting a patient on a biologic medication or new disease-modifying anti-rheumatic drug (DMARD) can be time consuming and frustrating for physicians, nurses and their support staff. In addition to educating the patient and obtaining prior…

    Florida Law Puts Drug Pricing by Pharmacy Benefit Managers Under a Microscope Once Again

    August 8, 2022

    As of July 1, a Florida bill increases oversight of pharmacy benefit managers and offers some protection for pharmacies. However, the legislation has limited effects on patients and providers, highlighting the need for additional reform.

    Stmool / shutterstock.com

    How to Avoid Cognitive Errors in Rheumatology

    March 14, 2022

    The 1999 Institute of Medicine report To Err Is Human gave a sobering depiction of the magnitude and consequences of medical error.1 The report concluded that approximately 98,000 people die in hospitals annually due to preventable medical errors. Of all the errors detailed in this report, diagnostic errors have since been determined to be the…

    What Pharmacists Want Rheumatologists to Know

    May 18, 2019

    Involving pharmacists in the management of chronic diseases benefits patients, says Wendy Ramey, BSPharm, RPh, CSP, a clinical pharmacy specialist in rheumatology at the University of Kentucky, Lexington. She knows this personally. As someone with rheumatoid arthritis (RA), Ms. Ramey knows pharmacists can play an important role in patient education and encouraging adherence to medications….

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences